Daxor Corporation

    Jurisdiction
    United States
    ISIN
    US2394671034 (DXR)
    Sectors
    1. Healthcare
    2. Medical - Instruments & Supplies

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Fundamental strength relative to industry (Mohanram G-Value)
    0 / 7

    Profile

    Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. Read full profile

    Fundamentals

    Net revenue
    €793.66K
    Gross margin
    92.0%
    EBIT
    €955.07K
    EBIT margin
    120.3%
    Net income
    €696.84K
    Net margin
    87.8%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.03
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 28K $228.34K +300 Buy

    Earnings Calls

    Latest earnings call: March 25, 2024 (Q4 2023)

    Add to watchlist

    Notifications